INTRODUCTION
In the United States, community-acquired pneumonia (CAP) results in an estimated 2 to 3 million diagnoses each year, 10 million physician visits, and 600,000 hospitalizations resulting in a total cost of over 20 billion dollars annually. 1 
Common causative organisms of CAP include Streptococcus pneumoniae, Haemophilus
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www.ajhm.org 2 influenzae, Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila. 1, 2 Identifying the etiologic organism helps guide therapeutic decisions, however, the pathogen remains unknown in about 50% of cases. 3 Therefore, optimal empiric therapy relies on a physician's experience and clinical judgment.
The Infectious Diseases Society of America (IDSA) guidelines for treatment of community-acquired pneumonia (CAP) recommend a minimum 5-day course of antibiotics for patients who achieve clinical stability within 48 to 72 hours from initiation of appropriate therapy. 4 A multicenter, cohort study of 686 patients hospitalized with CAP found that most were treated for 7 to 10 days despite median time to clinical stability of 3 days, indicating that a shorter duration of therapy is often not favored by clinicians despite guideline recommendations. 5 Moreover, although many patients receive active antimicrobial therapy while hospitalized, additional courses of antimicrobials are often prescribed upon discharge resulting in excessive antibiotic use. While many patients are given prolonged courses of therapy for CAP, shorter durations of antibiotics in patients eligible for such courses of treatment offer a number of advantages such as minimizing the emergence and selection of resistant organisms, increasing patient compliance, and reducing the risk of medication adverse effects. 6 The objective of this study was to assess the percentage of hospitalized patients diagnosed with uncomplicated CAP receiving antimicrobial therapy in excess of the guideline-recommended duration, evaluate subsequent thirty-day all-cause readmission rates, and determine if select co-morbidities influenced the length of antimicrobial therapy prescribed. , and treatment with antimicrobials active against the most common etiologies of CAP. Patients were excluded if they were on treatment with antimicrobials inactive against the most common etiologies of CAP, failed prior or initial antimicrobial therapy for CAP (defined as persistent fever greater than 38 degrees Celsius, malaise, cough, expectoration, or dyspnea after at least 72 hours of antimicrobial therapy), admitted to the intensive care unit, diagnosed with healthcare-associated pneumonia, ventilatorassociated pneumonia, or hospital-acquired pneumonia, or presented with signs and symptoms inconsistent with pneumonia or had concomitant infection at other sites.
METHODS
To determine eligibility for short course (5 days of) therapy, patients were assessed for clinical stability on day 5 of admission (or the last day of hospitalization if the patient was discharged prior to day 5). Patients were considered to be clinically stable if afebrile for 48 hours and if without signs of systemic inflammatory response Hahn et al.
www.ajhm.org 3 syndrome or altered mental status. 4, 6 Patients with a length of stay (LOS) less than 5 days were assumed to have met criteria for short course therapy. Duration of antimicrobial therapy was determined based on the sum of prescribed inpatient and outpatient days. Readmissions were categorized as pneumonia-related, medication-related, or unrelated. The Naranjo adverse drug reaction probability scale was used to assess nonspecific readmission complaints. 7 Descriptive statistics were used to assess the duration of antimicrobial therapy and baseline characteristics. Frequencies were used to determine the percentage of patients prescribed durations of therapy beyond guideline recommendations and readmission rates. Pearson's productmoment correlation coefficient was used to determine the association between number of comorbidities and total duration of therapy. This study was approved by the University of Texas Southwestern Institutional Review Board.
RESULTS
Of the initial 741 patients assessed for eligibility, 195 patients met all inclusion criteria and were considered eligible for short course therapy. Baseline demographics for this cohort were as shown in Table 1 
DISCUSSION
Overall, a majority of patients treated for CAP received durations of therapy exceeding national guideline recommendations resulting in a total of 645 excess days of antimicrobials. Additional antimicrobial therapy was often ordered at time of discharge. This retrospective review demonstrates that clinical practice often differs significantly from best practice guideline recommendations. The excess duration of and increased exposure to various antimicrobials increases costs of care, risk of resistant organism development, and decreases patient compliance and satisfaction. 8 Automatic stop dates and protocols to decrease duration of antibiotic therapy have been successful in the inpatient setting 9 . However, orders prescribed at discharge have been more challenging to prospectively identify and intervene upon in a similar fashion.
Hahn et al. www.ajhm.org This study has several limitations, including the retrospective nature of this analysis. The total duration of antibiotic therapy was composed of what patients received inpatient combined with what was stated on the discharge summary. Patients may not have filled the prescription or taken the total course of antimicrobial therapy as prescribed. Hospital emergency department visits and readmissions to outside facilities were unknown. In addition, clinical stability could not be assessed in patients with a LOS less than 5 days. However, if patients were stable enough to be discharged it may be reasonable to assume they would have met criteria. The severity of pneumonia was not directly determined by an objective measure. Rather, patients admitted to the intensive care unit were excluded and all assessable patients met clinical stability criteria required to discontinue therapy by day 5.
Despite the limitations of this study, overuse of antibiotic therapy is a clear problem in healthcare at present and treatment of uncomplicated CAP is an area in which antimicrobial use can easily be modified. These results reveal potential opportunities for antimicrobial stewardship and provider education regarding duration of therapy for CAP which may help improve prescribing practices and decrease antimicrobial overuse.
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